1. Home
  2. DVA vs FMS Comparison

DVA vs FMS Comparison

Compare DVA & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • FMS
  • Stock Information
  • Founded
  • DVA 1994
  • FMS 1996
  • Country
  • DVA United States
  • FMS Germany
  • Employees
  • DVA N/A
  • FMS N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • FMS Misc Health and Biotechnology Services
  • Sector
  • DVA Health Care
  • FMS Health Care
  • Exchange
  • DVA Nasdaq
  • FMS Nasdaq
  • Market Cap
  • DVA 12.2B
  • FMS 12.3B
  • IPO Year
  • DVA 1995
  • FMS 1996
  • Fundamental
  • Price
  • DVA $165.51
  • FMS $22.17
  • Analyst Decision
  • DVA Hold
  • FMS Hold
  • Analyst Count
  • DVA 5
  • FMS 2
  • Target Price
  • DVA $153.40
  • FMS $23.00
  • AVG Volume (30 Days)
  • DVA 1.0M
  • FMS 327.7K
  • Earning Date
  • DVA 10-29-2024
  • FMS 11-05-2024
  • Dividend Yield
  • DVA N/A
  • FMS 2.86%
  • EPS Growth
  • DVA 41.03
  • FMS 46.47
  • EPS
  • DVA 9.24
  • FMS 2.50
  • Revenue
  • DVA $12,666,614,000.00
  • FMS $21,457,738,113.00
  • Revenue This Year
  • DVA $6.17
  • FMS $0.24
  • Revenue Next Year
  • DVA $3.56
  • FMS $3.41
  • P/E Ratio
  • DVA $17.90
  • FMS $17.53
  • Revenue Growth
  • DVA 6.34
  • FMS N/A
  • 52 Week Low
  • DVA $98.26
  • FMS $17.93
  • 52 Week High
  • DVA $168.50
  • FMS $22.76
  • Technical
  • Relative Strength Index (RSI)
  • DVA 62.72
  • FMS 64.02
  • Support Level
  • DVA $154.05
  • FMS $21.42
  • Resistance Level
  • DVA $161.80
  • FMS $21.48
  • Average True Range (ATR)
  • DVA 4.24
  • FMS 0.30
  • MACD
  • DVA 1.71
  • FMS 0.11
  • Stochastic Oscillator
  • DVA 96.71
  • FMS 97.64

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

Share on Social Networks: